The assays measure phosphorylated tau 181 and apolipoprotein 4 to rule out whether a patient has Alzheimer's disease.

New trontinemab data continue to support rapid and deep, dose-dependent reduction of amyloid plaques in Phase Ib/IIa ...

CHF 27 million investment significantly bolsters Boehringer's ADC portfolio, driven by its subsidiary, NBE Therapeutics, to achieve the company’s ...

Annual Results/Sustainability03-Apr-2025 / 07:00 CET/CESTRelease of an ad hoc announcement pursuant to Art. 53 LRThe issuer is solely responsible for the content of this announcement.Ad hoc ...

Boehringer Ingelheim, via its subsidiary NBE Therapeutics, has launched a cutting-edge ADC research and development facility in Basel with a CHF ...

MUSETTE trial was designed to determine whether a higher dose of the currently approved OCREVUS IV 600 mg would provide additional benefit to people living with relapsing multiple sclerosis The trial ...

Hebrew University of Jerusalem and Technion at Haifa have completed a century of their service. These renowned institutions ...

Food & Wine's Global Tastemakers Awards celebrate the best in culinary travel, and this year's list for the best ...

NEW YORK, April 01, 2025 (GLOBE NEWSWIRE) -- In a release published March 27 by D S Simon, please note that the headline has changed. The company name has changed from Airbnb.org to Airbnb. The ...

Dido and Aeneas, and opera in three acts by Henry Purcell with text by Nahum Tate, is headed to Theater Basel. Learn more ...

IonQ (NYSE: IONQ), a leader in the quantum computing and networking industries, today announced that IonQ Forte Enterprise, ...

Chris Cargill, President and CEO of Nxera, commented: "I'm delighted to welcome Mr. Kaneko to our team at Nxera. His ...